Form 4: Roivant Sciences Director Melissa Epperly Reports Changes in Beneficial Ownership

Director Melissa Epperly reports acquisition and disposal of Roivant Sciences Ltd. common shares related to director compensation and tax obligations.

Summary

• On April 24, 2024, Melissa Epperly, a director of Roivant Sciences Ltd., reported changes in her beneficial ownership of the company's common shares.
• She acquired 1,146 common shares as part of the Issuer's Non-Employee Director Compensation Plan at a price of $0 per share, which were fully vested on the grant date.
• Epperly also disposed of 123 common shares at $10.9 per share to cover tax withholding obligations related to the vesting and settlement of previously granted shares.
• Following these transactions, Epperly beneficially owns 22,561 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing reflects routine transactions related to director compensation and tax obligations. There are no indications of significant positive or negative developments.

Positives

• The acquisition of shares through the Non-Employee Director Compensation Plan indicates continued alignment of director interests with shareholder value.

Negatives

• The disposal of shares to cover tax obligations, while routine, slightly reduces the director's holdings.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing is typical for directors receiving stock-based compensation and managing their tax obligations.

Comparison to Industry Standards

• Director compensation plans involving stock awards are common across the pharmaceutical and biotech industries.
• Companies like Pfizer, Johnson & Johnson, and AbbVie also utilize stock-based compensation to align director and shareholder interests.
• The specifics of Roivant's plan, such as vesting schedules and tax withholding procedures, would need to be compared to those of its peers to assess its competitiveness and effectiveness.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to director compensation and tax obligations.

Key Dates